Ankurit Capital buys 7.71 per cent stake in nutraceutical and cosmeceutical products firm Deccan Healthcare Ltd
- ByStartupStory | July 12, 2022
Ankurit Capital, an alternative investment firm, announced on Monday that it had chosen a 7.71 per cent interest in Deccan Healthcare Ltd., a manufacturer of nutraceutical and cosmeceutical goods. Deccan Healthcare said in a statement that it received 13.3 lakh equity shares as part of the deal, each worth Rs 37.6.
In an effort to dominate the direct-to-consumer (D2C) market, Deccan Healthcare would employ the additional funding for its digital transformation. The business also intends to increase its offline visibility and penetrate foreign markets in the US and the United Arab Emirates (UAE).
Minto Purshotam Gupta, chairman and managing director of Deccan Healthcare, stated in the release, “We are actively investigating placing our products in 600 retail outlets in the US, which is the largest market in our industry.”
Deccan Healthcare was established in 1996 and specialises in the development and production of nutraceutical and cosmeceutical products. According to the company, it currently offers more than 200 products to assist prevent and lowering the risk of more than 300 nutrient-deficient disorders.
The global market for combating senescence, or the process of degradation with age, is predicted to be worth more than $270 billion, according to Ntasha, co-founder and managing partner of Ankurit. “When a person reaches the age of 30, the ageing process speeds up. The Indian consumer’s demographics present a multi-billion dollar opportunity for this sector, ” she said.
Ankurit Capital has a Securities and Exchange Board of India registration (Sebi). According to the statement, it makes investments in a variety of sectors, including supply chain, healthtech, and fintech.
Follow Startup Story
Related Posts
